©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Dec 10, 2015; 6(6): 216-219
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.216
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.216
Direct therapeutic intervention for advanced pancreatic cancer
Kazuki Takakura, Shigeo Koido, Division of Gastroenterology and Hepatology, Department of Internal Medicine, the Jikei University School of Medicine, Tokyo 105-8461, Japan
Author contributions: Both authors contributed equally to this manuscript; Takakura K and Koido S conceived the issues which formed the content of the manuscript and wrote the manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Correspondence to: Kazuki Takakura, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, the Jikei University School of Medicine, Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan. ktakakura@jikei.ac.jp
Telephone: +81-3-34331111 Fax: +81-3-34350569
Received: May 5, 2015
Peer-review started: May 12, 2015
First decision: July 10, 2015
Revised: July 21, 2015
Accepted: September 7, 2015
Article in press: September 8, 2015
Published online: December 10, 2015
Processing time: 218 Days and 4 Hours
Peer-review started: May 12, 2015
First decision: July 10, 2015
Revised: July 21, 2015
Accepted: September 7, 2015
Article in press: September 8, 2015
Published online: December 10, 2015
Processing time: 218 Days and 4 Hours
Core Tip
Core tip: Unresectable, advanced pancreatic cancer (PC) has been still showed treatment-resistance and followed dismal prognosis in many cases with conventional therapies. Therefore, some sort of new, additional treatments are needed for the better therapeutic results for advanced PC. In recent years, interventional endoscopic ultrasonography (EUS) has been developed, disseminated and used efficiently all over the world as indispensable therapeutic strategies for PC. Therapeutic trials by interventional EUS for advanced PC until now, and describe the possibilities and expectations of anti-tumor therapy for advanced PC by interventional EUS to the future through this epoch-making deployment are summarized in this Editorial.